Oct 22 2009
MEBS, a leading provider of employee benefit services announced its sponsorship of the healthcare webcast series, “The E3 Advantage.” The next webcast will be on November 4th at 2 p.m. ET with the topic, “Looking into the Future of Healthcare” including “The Future of Pharmacy” presented by CVS Caremark. To attend, register at www.mebs.com.
The E3 Advantage, which represents engagement, empowerment, and enhancement, is a wellness and disease management initiative in response to requests by benefit administrators for answers to the many complex healthcare choices today. The webcasts quickly became popular by empowering attendees – who range from human resource administrators, insurance agents, union benefit administrators, and consumers, to make better decisions, develop smarter plans, and reduce healthcare costs without sacrificing quality benefits. The webcast attendees are encouraged to ask questions and provide comments during the presentation.
Host, Tim Spink, is a national leader and industry expert in consumer driven healthcare with over 15 years of experience. His guests are leading healthcare industry insiders and national insurance corporate division leaders.
“The E3 Advantage webcasts align perfectly with our mission of changing our member’s healthcare experience by providing insight on important health and wellness topics,” said Tim Spink, CEO of MEBS. “MEBS is passionate about delivering educational webcasts that empower consumers to make better decisions for better healthcare.”
The next webcast in the E3 Advantage Series, “Looking into the Future of Healthcare” will feature a powerhouse panel of industry experts to discuss how the upcoming healthcare and pharmacy trends will shape consumer’s behaviors and shake up the healthcare system. Previous webcasts are available on the MEBS website.
Other upcoming topics include:
- Using Healthcare Technology to Make Your Life Easier
- Creating Intelligent Plan Designs for Health Plans (Part I)
- Creating Intelligent Plan Designs for Pharmacy (Part II)